ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 337

$350K Total Retail Price of All Prescriptions

Rank: 134 out of 337

395 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,367 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 505 459 1 2
OMEPRAZOLE 456 388 2 4
HYDROCHLOROTHIAZIDE 328 318 3 9
SIMVASTATIN 305 282 4 1
AMLODIPINE BESYLATE 295 284 5 3
ATENOLOL 290 270 6 10
ATORVASTATIN CALCIUM 287 275 7 7
PRAVASTATIN SODIUM 247 247 8 14
METOPROLOL TARTRATE 208 196 9 6
FLUTICASONE PROPIONATE 197 177 10 34
LEVOTHYROXINE SODIUM 193 179 11 5
FUROSEMIDE 155 151 12 8
ALENDRONATE SODIUM 155 131 12 19
HYDROCODONE-ACETAMINOPHEN 126 86 S3 14 13
METFORMIN HCL 115 113 15 12
ZOLPIDEM TARTRATE 106 88 16 23
CITALOPRAM HBR 103 84 17 17
PAROXETINE HCL 103 69 17 46
LIPITOR 98 89 19 33
FELODIPINE ER 98 96 19 79
LOSARTAN POTASSIUM 96 96 21 15
ALLOPURINOL 93 93 22 28
TRAZODONE HCL 93 66 22 16
WARFARIN SODIUM 89 76 24 11
NEXIUM 79 76 25 56
DIOVAN 69 69 26 26
GLYBURIDE 67 67 R 27 53
TRIAMTERENE-HCTZ 67 58 27 39
METFORMIN HCL ER 66 64 29 52
SERTRALINE HCL 65 64 30 18
CLOPIDOGREL 64 53 31 42
PROAIR HFA 61 38 32 38
GABAPENTIN 57 31 33 20
LOVASTATIN 57 57 33 24
NAPROXEN 54 51 35 98
DOXAZOSIN MESYLATE 54 41 35 68
DILTIAZEM 24HR ER 51 51 37 76
ISOSORBIDE MONONITRATE ER 50 50 38 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.